Increased neurotrophic support, including insulin-like growth factor I (IGF-I), is an important aspect of the adaptive response to ischemic insult. However, recent findings indicate that the IGF-I receptor (IGF-IR) in neurons plays a detrimental role in the response to stroke. Thus, we investigated the role of astrocytic IGF-IR on ischemic insults using tamoxifen-regulated Cre deletion of IGF-IR in glial fibrillary acidic protein (GFAP) astrocytes, a major cellular component in the response to injury. Ablation of IGF-IR in astrocytes (GFAP-IGF-IR KO mice) resulted in larger ischemic lesions, greater blood-brain-barrier disruption and more deteriorated sensorimotor coordination. RNAseq detected increases in inflammatory, cell adhesion and angiogenic pathways, while the expression of various classical biomarkers of response to ischemic lesion were significantly increased at the lesion site compared to control littermates. While serum IGF-I levels after injury were decreased in both control and GFAP-IR KO mice, brain IGF-I mRNA expression show larger increases in the latter. Further, greater damage was also accompanied by altered glial reactivity as reflected by changes in the morphology of GFAP astrocytes, and relative abundance of ionized calcium binding adaptor molecule 1 (Iba 1) microglia. These results suggest a protective role for astrocytic IGF-IR in the response to ischemic injury.
AlbersGWMarksMPKempS, et al.
Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med2018;
378: 708–718.
5.
JoyMTCarmichaelST.Encouraging an excitable brain state: mechanisms of brain repair in stroke. Nat Rev Neurosci2021;
22: 38–53.
6.
WahlASSchwabME.Finding an optimal rehabilitation paradigm after stroke: enhancing fiber growth and training of the brain at the right moment. Front Hum. Neurosci2014;
7: 911.
7.
DavilaDTorres-AlemanI.Neuronal death by oxidative stress involves activation of FOXO3 through a Two-Arm pathway that activates stress kinases and attenuates insulin-like growth factor I signaling. Mol Biol Cell2008;
19: 2014–2025.
8.
FernandezAMFernandezSCarreroP, et al.
Calcineurin in reactive astrocytes plays a key role in the interplay between proinflammatory and anti-inflammatory signals. J Neurosci2007;
27: 8745–8756.
9.
DoyleKPSimonRPStenzel-PooreMP.Mechanisms of ischemic brain damage. Neuropharmacology2008;
55: 310–318.
10.
ArpaJSanz-GallegoIMedina-BaezJ, et al.
Subcutaneous insulin-like growth factor-1 treatment in spinocerebellar ataxias: an open label clinical trial. Mov Disord2011;
26: 358–359.
11.
HattonJKryscioRRyanM, et al.
Systemic metabolic effects of combined insulin-like growth factor-I and growth hormone therapy in patients who have sustained acute traumatic brain injury. J Neurosurg2006;
105: 843–852.
12.
KhwajaOSHoEBarnesKV, et al.
Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of rett syndrome. Proc Natl Acad Sci U S A2014;
111: 4596–4601.
13.
KolevzonABushLWangA, et al.
A pilot controlled trial of insulin-like growth factor-1 in children with Phelan-McDermid syndrome. Mol Autism2014;
5: 54.
14.
AbergDJoodKBlomstrandC, et al.
Serum IGF-I levels correlate to improvement of functional outcome after ischemic stroke. J Clin Endocrinol Metab2011;
96: E1055–E1064.
15.
De SmedtABrounsRUyttenboogaartM, et al.
Insulin-like growth factor I serum levels influence ischemic stroke outcome. Stroke2011;
42: 2180–2185.
16.
BakeSSelvamaniACherryJ, et al.
Blood brain barrier and neuroinflammation are critical targets of IGF-1-mediated neuroprotection in stroke for middle-aged female rats. PLoS One2014;
9: e91427.
17.
GuanJBennetLGluckmanPD, et al.
Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol2003;
70: 443–462.
18.
LiuYWangXLiW, et al.
A sensitized IGF1 treatment restores corticospinal axon-dependent functions. Neuron2017;
95: 817–833 e4.
19.
De GeyterDDe SmedtAStoopW, et al.
Central IGF-I receptors in the brain are instrumental to neuroprotection by systemically injected IGF-I in a rat model for ischemic stroke. CNS Neurosci Ther2016;
22: 611–616.
20.
LiuWD'ErcoleJAYeP.Blunting type 1 insulin-like growth factor receptor expression exacerbates neuronal apoptosis following hypoxic/ischemic injury. BMC Neurosci2011;
12: 64.
21.
EndresMPirizJGertzK, et al.
Serum insulin-like growth factor I and ischemic brain injury. Brain Res2007;
1185: 328–335.
22.
YanHMitschelenMTothP, et al.
Endothelin-1-induced focal cerebral ischemia in the growth hormone/IGF-1 deficient lewis dwarf rat. J Gerontol A Biol Sci Med Sci2014;
69: 1353–1362.
23.
De Magalhaes FilhoCDKappelerLDupontJ, et al.
Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin. J Cereb Blood Flow Metab2016;
37: 396–412.
24.
GanatYMSilbereisJCaveC, et al.
Early postnatal astroglial cells produce multilineage precursors and neural stem cells in vivo. J Neurosci2006;
26: 8609–8621.
25.
Garcia-CaceresCQuartaCVarelaL, et al.
Astrocytic insulin signaling couples brain glucose uptake with nutrient availability. Cell2016;
166: 867–880.
26.
HankeyGJ.Ischemic events after intracerebral hemorrhage: a new target for secondary prevention. JAMA Neurol2021;
78: 795–797.
27.
Pozo-RodrigálvarezAGradillasASerranoJ, et al.
New synthesis and promising neuroprotective role in experimental ischemic stroke of ONO-1714. Eur J Med Chem2012;
54: 439–446.
28.
BouetVBoulouardMToutainJ, et al.
The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc2009;
4: 1560–1564.
29.
LiYChoppMChenJ, et al.
Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab2000;
20: 1311–1319.
30.
TrejoJLCarroETorres-AlemanI.Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci2001;
21: 1628–1634.
31.
PfafflMW.A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res2001;
29: e45.
32.
ShenXYGaoZKHanY, et al.
Activation and role of astrocytes in ischemic stroke. Front Cell Neurosci2021;
15: 755955.
33.
OkoreehAKBakeSSohrabjiF.Astrocyte-specific insulin-like growth factor-1 gene transfer in aging female rats improves stroke outcomes. Glia2017;
65: 1043–1058.
34.
WieseSKarusMFaissnerA.Astrocytes as a source for extracellular matrix molecules and cytokines. Front Pharmacol2012;
3: 120.
35.
LambertsenKLClausenBHBabcockAA, et al.
Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci2009;
29: 1319–1330.
36.
OffnerHSubramanianSParkerSM, et al.
Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab2005;
26: 654–665.
37.
OwensTBabcockAAMillwardJM, et al.
Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res Brain Res Rev2005;
48: 178–184.
TakedaHYamaguchiTYanoH, et al.
Microglial metabolic disturbances and neuroinflammation in cerebral infarction. J Pharmacol Sci2021;
145: 130–139.
40.
BadautJAshwalSObenausA.Aquaporins in cerebrovascular disease: a target for treatment of brain edema?Cerebrovasc Dis2011;
31: 521–531.
41.
KitchenPSalmanMMHalseyAM, et al.
Targeting aquaporin-4 subcellular localization to treat Central nervous system edema. Cell2020;
181: 784–799 e19.
42.
EscartinCBonventoG.Targeted activation of astrocytes: a potential neuroprotective strategy. Mol Neurobiol2008;
38: 231–241.
43.
FreudeSSchilbachKHettichMM, et al.
Neuron-specific deletion of a single copy of the insulin-like growth factor-1 receptor gene reduces fat accumulation during aging. Horm Metab Res2012;
44: 99–104.
44.
BiondiOBranchuJBen SalahA, et al.
IGF-1R reduction triggers neuroprotective signaling pathways in spinal muscular atrophy mice. J Neurosci2015;
35: 12063–12079.
45.
GontierGGeorgeCChakerZ, et al.
Blocking IGF signaling in adult neurons alleviates Alzheimer's disease pathology through amyloid-beta clearance. J Neurosci2015;
35: 11500–11513.
46.
CohenEPaulssonJFBlinderP, et al.
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice. Cell2009;
139: 1157–1169.
47.
Garcia-SeguraLMRodriguezJRTorres-AlemanI.Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol1997;
26: 479–490.
48.
GazitNVertkinIShapiraI, et al.
IGF-1 receptor differentially regulates spontaneous and evoked transmission via mitochondria at hippocampal synapses. Neuron2016;
89: 583–597. (doi:10.1016/j.neuron.2015.12.034): 1–15.
49.
MardinlyARSpiegelIPatriziA, et al.
Sensory experience regulates cortical inhibition by inducing IGF1 in VIP neurons. Nature2016;
531: 371–375.
50.
HayesCAMorganNIThomasKC, et al.
Neuronal and astrocyte insulin-like growth factor-1 signaling differentially modulates ischemic stroke damage. bioRxiv2023. DOI: 10.1101/2023.04.02.535245.
51.
BakeSOkoreehAKAlanizRC, et al.
Insulin-Like growth factor (IGF)-1 modulates endothelial blood brain barrier function in ischemic middle-aged female rats. Endocrinology2015;
157: en20151840–69.
52.
LeeWHClemensJABondyCA.Insulin-like growth factors in the response to cerebral ischemia. Mol Cell Neurosci1992;
3: 36–43.
53.
HernandezVGLechtenbergKJPetersonTC, et al.
Translatome analysis reveals microglia and astrocytes to be distinct regulators of inflammation in the hyperacute and acute phases after stroke. Glia2023;
71: 1960–1984.
54.
LiangQSuLZhangD, et al.
CD93 negatively regulates astrogenesis in response to MMRN2 through the transcriptional repressor ZFP503 in the developing brain. Proc Natl Acad Sci U S A2020;
117: 9413–9422.
55.
KalinowskaALosyJ.PECAM-1, a key player in neuroinflammation. Eur J Neurol2006;
13: 1284–1290.
56.
TucićMStamenkovićVAndjusP.The extracellular matrix glycoprotein tenascin C and adult neurogenesis. Front Cell Dev Biol2021;
9: 674199.
57.
ChavezJCLaMannaJC.Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci2002;
22: 8922–8931.
58.
RyuWSChungJSchellingerhoutD, et al.
Biological mechanism of sex difference in stroke manifestation and outcomes. Neurology2023;
100: e2490–e2503.
59.
BushnellCDChaturvediSGageKR, et al.
Sex differences in stroke: challenges and opportunities. J Cereb Blood Flow Metab2018;
38: 2179–2191.
60.
JiaCLovinsCMaloneHM, et al.
Female-specific neuroprotection after ischemic stroke by vitronectin-focal adhesion kinase inhibition. J Cereb Blood Flow Metab2022;
42: 1961–1974.
61.
PeknyMPeknaM.Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev2014;
94: 1077–1098.
62.
WitcherKGEifermanDSGodboutJP.Priming the inflammatory pump of the CNS after traumatic brain injury. Trends Neurosci2015;
38: 609–620.
63.
MorizawaYMHirayamaYOhnoN, et al.
Reactive astrocytes function as phagocytes after brain ischemia via ABCA1-mediated pathway. Nat Commun2017;
8: 28.
64.
JiwajiZTiwariSSAvilés-ReyesRX, et al.
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to tau and Aß pathology. Nat Commun2022;
13: 135.
65.
KoizumiSHirayamaYMorizawaYM.New roles of reactive astrocytes in the brain; an organizer of cerebral ischemia. Neurochem Int2018;
119: 107–114.
66.
CherryJDMengGDaleyS, et al.
CCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy. J Neuroinflammation2020;
17: 370.
67.
LiddelowSAGuttenplanKAClarkeLE, et al.
Neurotoxic reactive astrocytes are induced by activated microglia. Nature2017;
541: 481–487.
68.
AbeNNishiharaTYorozuyaT, et al.
Microglia and macrophages in the pathological central and peripheral nervous systems. Cells2020;
9: 2132.
69.
LouNTakanoTPeiY, et al.
Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proc Natl Acad Sci U S A2016;
113: 1074–1079.
70.
BeckHSemischMCulmseeC, et al.
Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke. Am J Pathol2008;
173: 77–92.
71.
TureyenKBrooksNBowenK, et al.
Transcription factor early growth response-1 induction mediates inflammatory gene expression and brain damage following transient focal ischemia. J Neurochem2008;
105: 1313–1324.
72.
RibeiroM. d CHirtLBogousslavskyJ, et al.
Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res2006;
83: 1231–1240.
73.
TakanoTTianG-FPengW, et al.
Astrocyte-mediated control of cerebral blood flow. Nat Neurosci2006;
9: 260–267.
74.
PinardENalletHMacKenzieET, et al.
Penumbral microcirculatory changes associated with peri-infarct depolarizations in the rat. Stroke2002;
33: 606–612.
75.
NgaiACWinnHR.Modulation of cerebral arteriolar diameter by intraluminal flow and pressure. Circ Res1995;
77: 832–840.
76.
FernandezAMMartinez-RachadellLNavarreteM, et al.
Insulin regulates neurovascular coupling through astrocytes. Proc Natl Acad Sci U S A2022;
119: e2204527119.
77.
LiuLZhangKSandovalH, et al.
Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell2015;
160: 177–190.
78.
ChoudhuryGRDingS.Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol Dis2016;
85: 234–244.
79.
MuniveVSantiATorres-AlemanI.A concerted action of estradiol and insulin like growth factor I underlies sex differences in mood regulation by exercise. Sci Rep2016;
6: 25969–269.
80.
HowardVJMcDonnellMN.Physical activity in primary stroke prevention: just do it!. Stroke2015;
46: 1735–1739.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
